Psoriatic arthritis (PsA) is a complex inflammatory musculoskeletal and skin disease. The
treatment of PsA has changed substantially over the past 10 years. Clinical practice …

Colonization of the human nasopharynx by pneumococcus is extremely common and is both
the primary reservoir for transmission and a prerequisite for disease. Current vaccines …

Objective To update the European League Against Rheumatism (EULAR) recommendations
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …

Objectives To evaluate the reliability of consensus-based ultrasound (US) definitions of
elementary components of enthesitis in spondyloarthritis (SpA) and psoriatic arthritis (PsA) …

These guidelines were developed by the psoriasis research group of the French Society of
Dermatology with the aim of providing updated decision‐making algorithms for the systemic …

Background The objective was to compare different definitions of remission and low disease
activity (LDA) in patients with psoriatic arthritis (PsA), based on both patients' and physicians' …

Management recommendations are helpful for clinicians and patients because they provide
guidelines for the use of medications [1]. In psoriatic arthritis (PsA), several recommendation …

Background Prevalence and outcomes of coronavirus disease (COVID)-19 in relation to
immunomodulatory medications are still unknown. The aim of the study is to investigate the …

Abstract Objective The Italian board for the TAilored BIOlogic therapy (ITABIO) reviewed the
most consistent literature to indicate the best strategy for the second-line biologic choice in …

Introduction An unbalanced intestinal microbiota may mediate activation of the inflammatory
pathways seen in psoriatic arthritis (PsA). A randomised, placebo-controlled trial of faecal …